Look for:

Our offer for

BAYER AG


ISIN:
DE000BAY0017
WKN:
BAY001

2024/02/21 13:32:36
Price
27.607 CHF
Difference 2.09% (0.56)

General attributes

ISINDE000BAY0017
SymbolBAYN
ExchangeBX Swiss
CurrencyCHF
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)28,259 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)27.348 CHF (11,556)
Ask (Ask size)27.393 CHF (11,556)
Open27.547 CHF
High27.607 CHF
Low27.536 CHF
Close (prev. day)27.042 CHF
VWAP27.570026 CHF
Volume (pcs)2,060
Trading volume56,794.20
Number of trades7
Last size1

Futures and Options

Related Futures54
Related Options-

PDF Downloads

Company report: BAYER AGPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/02/21 13:32:36
Price
27.607 CHF
Difference 2.09% (0.56)

General attributes

ISINDE000BAY0017
SymbolBAYN
ExchangeBX Swiss
CurrencyCHF
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)28,259 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)27.348 CHF (11,556)
Ask (Ask size)27.393 CHF (11,556)
Open27.547 CHF
High27.607 CHF
Low27.536 CHF
Close (prev. day)27.042 CHF
VWAP27.570026 CHF
Volume (pcs)2,060
Trading volume56,794.20
Number of trades7
Last size1

Performance and Risk

6m1Y3Y
Perf (%)-43.90%-54.72%-
Perf (abs.)-21.16-32.68-
Beta1.291.000.79
Volatility38.3434.39-
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)26.954 CHF (881)
Ø price 30 days | Ø volume 30 days (pcs.)28.827 CHF (814)
Ø price 100 days | Ø volume 100 days (pcs.)33.342 CHF (811)
Ø price 250 days | Ø volume 250 days (pcs.)42.818 CHF (450)
YTD High | date33.288 CHF (2024/01/09)
YTD Low | date25.912 CHF (2024/02/09)
52 Weeks High | date60.562 CHF (2023/04/18)
52 Weeks Low | date25.912 CHF (2024/02/09)

All listings for BAYER AG

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2024/02/2114:4528.795 EUR59.557,455
Vienna Stock Exchange2024/02/2109:0528.955 EUR0.001
Tradegate2024/02/2114:4428.83 EUR9.451,025
Stuttgart2024/02/2114:4528.805 EUR0.73137
SIX Swiss Exchange2022/06/0215:20195.7691 CHF0.001
SIX Swiss Exchange2023/02/2117:3560.00 EUR0.001
Munich2024/02/2111:4429.08 EUR0.065
London Stock Exchange European Trade Reporting2024/02/2109:0028.72 EUR0.004
Hanover2024/02/2112:3728.915 EUR0.002
Hamburg2024/02/2113:3329.04 EUR0.099
Frankfurt2024/02/2114:3528.805 EUR0.2842
FINRA other OTC Issues2024/02/2018:3831.043 USD0.0818
Euronext Milan MTF Trading After Hours2024/02/1920:0528.50 EUR0.026
Euronext Milan MTF Global Equity Market2024/02/2114:4128.845 EUR0.4083
Duesseldorf2024/02/2112:3128.93 EUR0.015
Budapest Stock Exchange2024/02/2114:1711,226.00 HUF3.944
Bucharest Stock Exchange2024/02/2111:09144.00 RON0.016
Berlin2024/02/2114:1328.88 EUR0.0412
BX Swiss2024/02/2113:3227.607 CHF0.067

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=958&ID_TYPE_IMAGE_LOGO=2

Contact Details

BAYER AG
- -
Kaiser-Wilhelm-Allee 1 - 51368 Leverkusen
Telefon: +49-214-30-1
Fax: +
E-mail: -

PDF Downloads

Company report: BAYER AGPDF Download

Company Profile

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Members of Management Board

Werner BaumannChairman of Managing Board
Heiko SchipperMember of Executive Committee
Rodrigo SantosMember of Executive Committee
Sarena LinMember of Executive Committee
Stefan OelrichMember of Executive Committee
Wolfgang NicklMember of Executive Committee

Board of directors

Norbert WinkeljohannChairman of Supervisory Board
Barbara GansewendtMember of Supervisory Board
Norbert BischofbergerMember of Supervisory Board
Otmar WiestlerMember of Supervisory Board
Paul AchleitnerMember of Supervisory Board
Simone Bagel-TrahMember of Supervisory Board
Alberto WeisserMember of Supervisory Board
Andrea SacherMember of Supervisory Board
André van BroichMember of Supervisory Board
Claudia SchadeMember of Supervisory Board
Colleen GogginsMember of Supervisory Board
Ertharin CousinMember of Supervisory Board
Francesco GrioliMember of Supervisory Board
Frank LöllgenMember of Supervisory Board
Heike HausfeldMember of Supervisory Board
Heinz Georg WebersMember of Supervisory Board
Horst Heinz Paul BaierMember of Supervisory Board
Kimberly MathisenMember of Supervisory Board
Michael WestmeierMember of Supervisory Board
Yasmin FahimiMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer